Garmin Ltd.
GRMNGarmin Ltd. is strength at full price. The numbers are improving — and a P/E at the 99th percentile of its own range says the market knows.
The sharpest disagreement: the engine is strong, but at the 99th percentile of its own range you are paying full price for it.
The price is in a confirmed uptrend (12 weeks in) while the P/E sits at the 99th percentile of its own 4-year range. Underneath, the last four quarters read improving — profit +24.2% year on year, and 102% of the last 3 years' profit arrived as cash. What settles it: whether the earnings grow into the multiple.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Garmin Ltd. trades at $307, in a confirmed uptrend and 12 weeks into that stage. That is +33.7% against its own 200-day average. It sits at 100% of a 52-week range of $192 to $307. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks.
Today the stock is in a confirmed uptrend — week 12 of stage 2. At $307 it trades +33.7% versus its 200-day average and sits at 100% of its 52-week range ($192–$307).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +609% while the S&P 500 moved +263% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 2 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Garmin Ltd. trades at 31.7× P/E, about the priciest it has ever traded. Its long-run median P/E is 23.0×, measured across 4.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 31.7× is about the priciest it has ever traded, against a long-run median of 23.0× measured over 4.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +17.7% against a +40.5% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +42.5%/yr price move, ~+20.2%/yr came from earnings growth and ~+22.3 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Garmin Ltd. reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 25.7% and holding. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +15.1% | +14.3% | — | — |
| Profit | +17.7% | +19.6% | — | — |
| EPS | +17.7% | +19.5% | — | — |
| Stock price | +40.5% | +42.5% | +13.1% | +18.8% |
4-Factor Sector Score
66.3/100 — rank 2 of 19 in Scientific & Technical Instruments · 56% evidence confidence
Garmin Ltd. scores 66.3 out of 100 against the 19 companies it is compared with in Scientific & Technical Instruments, ranking 2. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 21.3 + 17 + 10.8 + 17.2 = 66.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Garmin Ltd. reported $1.8 B of revenue in the Mar 26 quarter, +13.6% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 9.8% a year. The last full year, FY25, came in at $7.3 B. The last four reported quarters add to $7.5 B.
FY25 revenue came in at $7.3 B (+15.1% on the year), capping 4 years at 9.8% compound. The latest quarter (Mar 26) printed $1.8 B, +13.6% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +15.3% growth against the decade's 9.8% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +15.3% over the last 4 quarters against +16.8%/yr over the last 8 — stabilising; TTM profit +18.4% vs +12.7%/yr — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Garmin Ltd.'s operating margin is 24.6% in the Mar 26 quarter, +3.2 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 20.8% to 25.9%. The current quarter sits inside that band.
The latest quarter's operating margin is 24.6%, +3.2 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 20.8%–25.9%, and FY25's 25.9% is the top of that band — a record year.
Why the margin moved: operating margin went +3.2 pp year on year while gross margin went +2.3 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Garmin Ltd. earned $0.4 B of net profit in the Mar 26 quarter, +24.2% year on year. It is the 2nd consecutive quarter of growth. Full-year FY25 profit was $1.7 B. The 4-year compound rate is 11.3%. That is 23.4% of the quarter's revenue. The same quarter a year earlier earned $0.3 B.
Mar 26 profit was $0.4 B, +24.2% year on year — the 2nd consecutive quarter of growth. On the full year, FY25 printed $1.7 B (+17.7%), and the 4-year compound rate is 11.3%.
Why profit moved: revenue contributed +13.6% and the margin +3.2 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +19.5% vs revenue +15.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 102% of Garmin Ltd.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $1.6 B of operating cash against $1.7 B of profit. After $0.3 B of capital spending, $1.4 B was left as free cash.
FY25: operating cash of $1.6 B against reported profit of $1.7 B, leaving free cash of $1.4 B after $0.3 B of capital spending. Across the last 3 fiscal years the conversion rate is 102% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Garmin Ltd. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 4.6% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Garmin Ltd. earns a ROE of 19% in FY25. That is up from a trough of 16% in FY22. Return on invested capital clears the cost of that capital by +17.0 percentage points, so growth here adds value rather than only size. The wiring behind it is 22.9% net margin on 0.66× asset turns.
FY25 ROE is 19%, recovered from a FY22 trough of 16% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 22.9% net margin × 0.66× asset turns × 1.23× balance-sheet leverage ≈ 18.6% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 26.2% − 9.2% = a +17.0 pp spread. The 9.2% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Garmin Ltd. has 3 quarters of declared dividends on file — too few for a trailing-twelve-month figure. The most recent declaration was $4.20 for Mar 26.
Garmin Ltd. has declared a dividend in 3 of the last 12 reported quarters, most recently $4.20 for Mar 26. That is fewer than four quarters, so no trailing-twelve-month total is shown rather than one built from a partial year.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Garmin Ltd. carries total debt of $0.2 B against shareholder equity of $9.0 B as of Jun 26, a debt-to-equity of 0.02 — effectively unlevered. On the annual view that ratio went from 0.01 in FY20 to 0.02 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.
Jun 26: total debt of $0.2 B against shareholder equity of $9.0 B — a debt-to-equity of 0.02. On the annual view, debt-to-equity went from 0.01 (FY20) to 0.02 (FY25). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
1.2% of Garmin Ltd.'s tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 4.3 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 1.2% of the float is sold short, and at typical trading volumes it would take about 4.3 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Garmin Ltd.: the Z-score reads 13.63. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 13.63 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 13.63.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Keysight Technologies, Inc.KEYS | 67.2/100Favorable setup81% evidence | ASLEEP | 28.4/35 Revenue 19.2% · PAT 44.6% · OPM change 7.9 pp 83% evidence | 15.0/25 ROCE 4.5% · OPM 23.7% 76% evidence | 11.3/20 P/E 57.6× · PEG 1.35 65% evidence | 12.5/20 RS sector 14.9% · RS bench 22.7% · 1Y 106.9%4 of 12 weeks ahead 100% evidence |
| Exact sum: 28.4 + 15 + 11.3 + 12.5 = 67.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Garmin Ltd.this pageGRMN | 66.3/100Thin evidence · provisional56% evidence | TURNING | 21.3/35 Revenue — · PAT — · OPM change 2.9 pp 39% evidence | 17.0/25 ROCE 6.9% · OPM 24.6% 76% evidence | 10.8/20 P/E 24× · PEG — 15% evidence | 17.2/20 RS sector 9.7% · RS bench 18.7% · 1Y 32.3%2 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 17 + 10.8 + 17.2 = 66.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Cognex CorporationCGNX | 59.9/100Thin evidence · provisional56% evidence | FADING | 22.3/35 Revenue — · PAT — · OPM change 4.9 pp 39% evidence | 14.9/25 ROCE 3.4% · OPM 22.3% 76% evidence | 9.4/20 P/E 58.5× · PEG — 15% evidence | 13.3/20 RS sector 19.6% · RS bench 28.4% · 1Y 74.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 22.3 + 14.9 + 9.4 + 13.3 = 59.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4MKS Inc.MKSI | 56.4/100Mixed-positive evidence66% evidence | FADING | 19.6/35 Revenue 11.5% · PAT 43.4% · OPM change 1.9 pp 53% evidence | 10.2/25 ROCE 2.1% · OPM 13.8% 57% evidence | 12.8/20 P/E 48.1× · PEG 1.13 65% evidence | 13.8/20 RS sector 22.9% · RS bench 30.5% · 1Y 222.8%10 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 10.2 + 12.8 + 13.8 = 56.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Novanta Inc.NOVT | 54.3/100Thin evidence · provisional56% evidence | BREAKING OUT | 21.4/35 Revenue — · PAT — · OPM change 4.5 pp 39% evidence | 9.8/25 ROCE 2% · OPM 10.7% 76% evidence | 8.9/20 P/E 84.8× · PEG — 15% evidence | 14.2/20 RS sector 2.8% · RS bench 10.9% · 1Y 37.9%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.4 + 9.8 + 8.9 + 14.2 = 54.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Ituran Location and Control Ltd.ITRN | 53.1/100Thin evidence · provisional60% evidence | ASLEEP | 15.8/35 Revenue 11.3% · PAT 6.9% · OPM change -0.1 pp 53% evidence | 15.9/25 ROCE 8.6% · OPM 21.5% 57% evidence | 10.5/20 P/E 16.2× · PEG 1.8 65% evidence | 10.9/20 RS sector -0.1% · RS bench 7.3% · 1Y 34.1%6 of 12 weeks ahead 70% evidence |
| Exact sum: 15.8 + 15.9 + 10.5 + 10.9 = 53.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Coherent Corp.COHR | 52.4/100Thin evidence · provisional56% evidence | ASLEEP | 23.2/35 Revenue 18% · PAT 100% · OPM change 6.3 pp 53% evidence | 7.7/25 ROCE 1.4% · OPM 11.1% 57% evidence | 8.5/20 P/E 114× · PEG — 15% evidence | 13.0/20 RS sector 21.8% · RS bench 29.1% · 1Y 180.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 23.2 + 7.7 + 8.5 + 13 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Teledyne Technologies IncorporatedTDY | 51.3/100Thin evidence · provisional56% evidence | TURNING | 17.8/35 Revenue — · PAT — · OPM change 1 pp 39% evidence | 13.0/25 ROCE 2.5% · OPM 18.9% 76% evidence | 10.6/20 P/E 30.1× · PEG — 15% evidence | 9.9/20 RS sector -3.9% · RS bench 3.8% · 1Y 25.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.8 + 13 + 10.6 + 9.9 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Sensata Technologies Holding plcST | 50.7/100Thin evidence · provisional56% evidence | FADING | 18.2/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence | 11.0/25 ROCE 2.7% · OPM 15.1% 76% evidence | 9.0/20 P/E 79.6× · PEG — 15% evidence | 12.5/20 RS sector 8.6% · RS bench 16.8% · 1Y 65.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 18.2 + 11 + 9 + 12.5 = 50.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Vontier CorporationVNT | 49.3/100Thin evidence · provisional56% evidence | TURNING | 16.1/35 Revenue — · PAT — · OPM change 0.4 pp 39% evidence | 14.7/25 ROCE 3.6% · OPM 18% 76% evidence | 11.3/20 P/E 12.5× · PEG — 15% evidence | 7.2/20 RS sector -24.2% · RS bench -17.3% · 1Y -16.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 14.7 + 11.3 + 7.2 = 49.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11ESCO Technologies Inc.ESE | 47.0/100Mixed-negative evidence66% evidence | TURNING | 17.7/35 Revenue 30.7% · PAT 16.7% · OPM change -0.5 pp 53% evidence | 13.1/25 ROCE 2.8% · OPM 15.5% 57% evidence | 4.7/20 P/E 54.2× · PEG 6 65% evidence | 11.5/20 RS sector 6.9% · RS bench 14.8% · 1Y 68.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 13.1 + 4.7 + 11.5 = 47 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Trimble Inc.TRMB | 46.2/100Thin evidence · provisional56% evidence | BASING | 20.2/35 Revenue — · PAT — · OPM change 3.7 pp 39% evidence | 10.5/25 ROCE 1.9% · OPM 15.3% 76% evidence | 10.4/20 P/E 33.1× · PEG — 15% evidence | 5.1/20 RS sector -29.8% · RS bench -23.1% · 1Y -28.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 10.5 + 10.4 + 5.1 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Badger Meter, Inc.BMI | 46.2/100Thin evidence · provisional56% evidence | TURNING | 13.7/35 Revenue — · PAT — · OPM change -4.8 pp 39% evidence | 15.4/25 ROCE 4.8% · OPM 17.4% 76% evidence | 10.1/20 P/E 34.7× · PEG — 15% evidence | 7.0/20 RS sector -27.5% · RS bench -20.6% · 1Y -25.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 13.7 + 15.4 + 10.1 + 7 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Itron, Inc.ITRI | 44.2/100Thin evidence · provisional56% evidence | TURNING | 14.6/35 Revenue — · PAT — · OPM change -1.1 pp 39% evidence | 9.8/25 ROCE 2.5% · OPM 11.5% 76% evidence | 11.1/20 P/E 14.4× · PEG — 15% evidence | 8.7/20 RS sector -12.4% · RS bench -4.2% · 1Y -15.3%2 of 12 weeks ahead 100% evidence |
| Exact sum: 14.6 + 9.8 + 11.1 + 8.7 = 44.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Vishay Precision Group, Inc.VPG | 42.5/100Thin evidence · provisional56% evidence | LEADER | 13.3/35 Revenue — · PAT — · OPM change -3.2 pp 39% evidence | 4.5/25 ROCE 0.1% · OPM 0.4% 76% evidence | 8.7/20 P/E 99.5× · PEG — 15% evidence | 16.0/20 RS sector 48.6% · RS bench 56.9% · 1Y 271.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 4.5 + 8.7 + 16 = 42.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Fortive CorporationFTV | 41.5/100Thin evidence · provisional53% evidence | ASLEEP | 15.8/35 Revenue — · PAT — · OPM change -5.6 pp 32% evidence | 8.6/25 ROCE 1.7% · OPM 9% 76% evidence | 10.3/20 P/E 33.3× · PEG — 15% evidence | 6.8/20 RS sector -9.3% · RS bench -1.9% · 1Y 28.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 8.6 + 10.3 + 6.8 = 41.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Mesa Laboratories, Inc.MLAB | 39.8/100Thin evidence · provisional51% evidence | ASLEEP | 16.1/35 Revenue 3.7% · PAT — · OPM change 1.9 pp 40% evidence | 6.3/25 ROCE 0.9% · OPM 4.3% 57% evidence | 9.2/20 P/E 73.1× · PEG — 15% evidence | 8.2/20 RS sector -1.5% · RS bench 6% · 1Y 57.3%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 6.3 + 9.2 + 8.2 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18USBC, Inc.USBC | 43.4/100Thin evidence · provisional20% evidence | ASLEEP | 17.3/35 Revenue — · PAT — · OPM change — 2% evidence | 11.1/25 ROCE — · OPM — 11% evidence | 11.5/20 P/E 0.9× · PEG — 15% evidence | 3.5/20 RS sector -54% · RS bench -48.9% · 1Y -84.2%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17.3 + 11.1 + 11.5 + 3.5 = 43.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19MicroVision, Inc.MVIS | 30.4/100Thin evidence · provisional39% evidence | 10.6/35 Revenue -80% · PAT — · OPM change -129 pp 40% evidence | 6.8/25 ROCE -35.2% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.0/20 RS sector -68.3% · RS bench -66.3% · 1Y -76.9%0 of 10 weeks ahead 70% evidence | |
| Exact sum: 10.6 + 6.8 + 10 + 3 = 30.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Garmin Ltd.'s stock price today?
Garmin Ltd. trades at $307, +40.5% over the past year. The company is valued at $59.0 B. The stock sits at 100% of its 52-week range of $192–$307, +33.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 12 weeks in. — as of 5 August 2026.
What were Garmin Ltd.'s latest quarterly results?
Garmin Ltd. reported revenue of $1.8 B and net profit of $0.4 B for the Mar 26 quarter. Revenue rose 13.6% and profit rose 24.2% year on year. Earnings per share were $2.09. The operating margin was 24.6%, 3.2 pp higher than a year earlier. — as of 5 August 2026.
What is Garmin Ltd.'s revenue?
Garmin Ltd. reported revenue of $1.8 B in the Mar 26 quarter, +13.6% year on year. For the full FY25 fiscal year, revenue was $7.3 B (+15.1%). Over the last 4 years revenue compounded at 9.8% a year. — as of 5 August 2026.
What is Garmin Ltd.'s profit?
Garmin Ltd. earned $0.4 B of net profit in the Mar 26 quarter, +24.2% year on year — the 2nd straight quarter of growth. Full-year FY25 profit was $1.7 B. The operating margin ran 24.6% in the latest quarter. — as of 5 August 2026.
What is Garmin Ltd.'s market cap?
Garmin Ltd.'s market capitalisation is $59.0 B at a stock price of $307. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Garmin Ltd.'s P/E ratio?
Garmin Ltd. trades at a P/E of 31.7×, at the 99th percentile of its own 4-year range, against a long-run median of 23.0×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Garmin Ltd. pay a dividend?
Yes — Garmin Ltd. declared $4.20 per share for Mar 26 (3 quarters on file, too few for a trailing-twelve-month total). The latest quarter is up 16.7% on the same quarter a year earlier. — as of 5 August 2026.
What is Garmin Ltd.'s dividend per share?
Garmin Ltd.'s most recently declared dividend is $4.20 per share for Mar 26. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
Is Garmin Ltd. overvalued?
On its own history, Garmin Ltd. looks expensive against its own history: its P/E of 31.7× sits at the 99th percentile of its 4-year range (long-run median 23.0×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.
Is Garmin Ltd. growing?
Yes — Garmin Ltd. is growing: latest-quarter revenue +13.6% year on year, profit +24.2%, and the margin +3.2 pp at 24.6%. The 4-year compound rates are 9.8% (revenue) and 11.3% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is Garmin Ltd. performing?
Garmin Ltd. is in a confirmed uptrend, 12 weeks in. Its latest quarter's revenue rose 13.6% and profit rose 24.2% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Garmin Ltd. in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 25.7% and holding. The read comes from the last 12 quarters of growth (revenue growth +15.3% latest, profit growth +18.4% latest, eps growth +18.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Garmin Ltd. in an uptrend?
Yes — the price is in a confirmed uptrend (week 12 of stage 2), trading +33.7% versus its 200-day average and at 100% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Garmin Ltd. beating the market?
On recent form, yes — Garmin Ltd. has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +609% against the S&P 500's +263% — ahead of the index over the full window. — as of 5 August 2026.
Will Garmin Ltd.'s stock price go up?
This page publishes no price forecast for Garmin Ltd. What it measures instead: the stock price is $307, the price is in a confirmed uptrend 12 weeks in. Its P/E of 31.7× sits at the 99th percentile of its own 4-year range. — as of 5 August 2026.
Is the market betting against Garmin Ltd.?
No — short interest is 1.2% of Garmin Ltd.'s tradable float, about 4.3 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Garmin Ltd. have too much debt?
No — Garmin Ltd.'s debt-to-equity is 0.03. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 5 August 2026.
What is Garmin Ltd.'s capex?
Garmin Ltd. spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.3 B. — as of 5 August 2026.
What is Garmin Ltd.'s cash flow?
Garmin Ltd. generated $1.6 B of operating cash flow in FY25 and $1.4 B of free cash flow after $0.3 B of capital spending. Reported profit that year was $1.7 B, so operating cash ran behind profit. — as of 5 August 2026.
Is Garmin Ltd.'s profit real cash?
Yes — over the last 3 fiscal years, 102% of Garmin Ltd.'s reported profit arrived as operating cash. In FY25, operating cash was $1.6 B against reported profit of $1.7 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Garmin Ltd.?
On the balance sheet, the Z-score reads 13.63 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is Garmin Ltd. in its business cycle?
Garmin Ltd.'s FY25 operating margin was 25.9%, against a 5-year band of 20.8%–25.9%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 24.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Garmin Ltd. story?
The sharpest disagreement: the engine is strong, but at the 99th percentile of its own range you are paying full price for it. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Garmin Ltd. a stock worth studying right now?
This is not investment advice. The machine read: Garmin Ltd. is strength at full price. The numbers are improving — and a P/E at the 99th percentile of its own range says the market knows. The sharpest open question: whether the earnings grow into the multiple. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.